A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03484520 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Cancer - Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Dinaciclib

Sponsor

AbbVie

Collaborators

[object Object]